Girl's meningitis leads to quadruple amputation
The family of a five-year-old girl who had a quadruple amputation after contracting a rare form of meningitis said the "fact she's alive is a huge miracle".
Saffanah, from Stockton-on-Tees, fell ill in January after complaining of a stiff neck and light sensitivity, and within 24 hours she was in an induced coma.
Her khalas - which is the Urdu word for aunties - praised the NHS who worked "tirelessly" to save their niece's life.
They have organised a community event later in the month to raise awareness of symptoms and to help people get used to Saffanah's "new normal".
The youngster's infection led to meningococcal septicaemia.
Doctors told her family that if her mother had not taken her to urgent care that morning, she would not have survived.
Her symptoms included a rash on her forehead, a headache and vomiting.
Saffanah had all of her vaccinations, but the MenACWY vaccine is only offered to teenagers and students going to university for the first time - so she was not protected from the Y variant of the disease she had contracted.
One of her khalas, Zulaikha Zeb, said it was a very rare infection and it was not known where she picked it up.
"We don't know how it's happened," she said.
The family said they had worked with Public Health England to track where the infection had come from, but it was inconclusive.
They were all given precautionary antibiotics as soon as Saffanah was diagnosed.
How can I spot the signs of meningitis?
Saffanah had her lower legs and forearms amputated in March at Newcastle's Royal Victoria Infirmary as a result of compartment syndrome.
Khala Taiba Shafiq said it had been a "rollercoaster" but Saffanah was back to her "sassy self".
The family said they were unsure whether she understood she had lost the lower parts of her limbs because she was still in bandages.
Saffanah's forearms were removed just below her elbows. Taiba said her niece uses them to "tickle us, and scratch her head and play guess who?"
Mrs Zeb added: "She's mostly asking questions around doing stuff, like how she's going to get to places rather than asking: 'What's happened to me?'"
Khala Zainab Nabeel said faith and family had got them through the last few months.
"We are so lucky to be under the NHS," Mrs Nabeel said.
"They have worked tirelessly to save our niece's life."
Saffanah's khalas - who all work in healthcare on Teesside - made a plea to their community not to discriminate against her when she returns from hospital.
"She's normal, she's absolutely normal," Mrs Nabeel said.
"She's a limb difference baby and we need to let the community know that we're proud of how far she's come and we want them to be proud as well."
They are holding a talk in Stockton on 28 April and have invited a guest speaker who has a lived experience of amputations.
Follow BBC Tees on X, Facebook, Nextdoor and Instagram.
'My hand transplant changed my life'
Concerned manager saves colleague with meningitis
Mum fundraising for son who lost limbs to sepsis
NHS - Meningitis
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 hours ago
- Yahoo
Weight loss jabs linked to potentially fatal side effects, says new report
Hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes jabs, prompting health officials to launch a new study into side effects. Some cases of pancreatitis reported to be linked to GLP-1 medicines (glucagon-like peptide-1 receptor agonists) have been fatal. Data from the medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), shows that since the drugs were licensed there have been hundreds of cases of acute and chronic pancreatitis among people taking GLP-1 medicines. The new weight management medication 'Tirzepatide' (brand name Mounjaro®) is shortly being made available to NHS patients to support weight loss. Access is prioritised for those with the greatest clinical need. You can find out more at: — NHS Cheshire and Merseyside (@NHSCandM) June 24, 2025 This includes: 181 reported cases of acute and chronic pancreatitis linked to tirzepatide – the active ingredient for Mounjaro. Five people died. 116 reported reactions of this kind linked to liraglutide, one of which was fatal. 113 cases of acute and chronic pancreatitis linked to semaglutide – the active ingredient for Ozempic and Wegovy. One person died. 101 reported reactions of this kind linked to exenatide, three people died. 52 reported reactions of this sort linked to dulaglutide and 11 reported reactions lixisenatide. No fatalities were linked to either drug. These cases are not confirmed as being caused by the medicines, but the person who reported them suspected they may be. Review your ICB's local policy about treating patients with tirzepatide (Mounjaro) for weight management in a primary care setting and visit: — We are Primary Care (@PrimaryCareNHS) June 27, 2025 Nonetheless, Yellow Card Biobank project, launched by the MHRA and Genomics England, will see researchers examine whether cases of pancreatitis linked to GLP-1 drugs may be influenced by peoples genetic makeup. The MHRA is calling for people who are taking GLP-1 medicine who have been admitted to hospital due to acute pancreatitis to submit a report to its Yellow Card scheme. When a Yellow Card report is received, the MHRA will contact patients to ask if they would be willing to take part in the study. Patients will be asked to submit more information and a saliva sample which will be assessed to explore whether some people are at a higher risk of acute pancreatitis when taking these medicines due to their genes. GLP-1 agonists can lower blood sugar levels in people living with type 2 diabetes and can also be prescribed to support some people with weight loss. 🧵Weight loss jab roll out 'positive for patients' but with implications for general practice that must be considered. Our Chair Kamila Hawthorne has featured widely in the national press and broadcast media responding to the phased roll-out of Mounjaro prescriptions by NHS… — Royal College of General Practitioners (@rcgp) June 23, 2025 Chronic stress and poor sleep are major weight loss blockers. Stress increases cortisol, a hormone linked to fat retention, especially around the abdomen. Sleep deprivation increases ghrelin (hunger hormone) and decreases leptin (fullness hormone), making you more likely to overeat and less likely to move. You're also more impulsive and less motivated when sleep-deprived, making it harder to stick to your diet and exercise routine. As a solution, prioritise stress management techniques (like mindfulness or journaling), and aim for 7-9 hours of sleep per night. Medical issues such as PCOS, diabetes, hypothyroidism, or insulin resistance can all interfere with weight loss. Similarly, certain medications (like antidepressants or steroids) may cause weight gain or inhibit fat loss. If weight loss stalls despite doing everything right, consult your GP to rule out or address any underlying conditions. If you have a known medical condition, it's important to stay up to date with your routine reviews and inform your GP or specialist about any weight loss treatments you're using. Regular follow-up helps ensure your treatment plan remains safe and effective. More Mounjaro news... Who is eligible for Mounjaro on the NHS? Urgent holiday warning for Mounjaro users issued Mounjaro warning as summer temperatures rise Recent estimates suggest that about 1.5 million people in the UK are taking weight loss jabs. Health officials have suggested that they can help to turn the tide on obesity, but have stressed they are not a silver bullet and do come with side effects. Most side effects linked to the jabs are gastrointestinal including nausea, constipation and diarrhoea. And the medical regulator recently warned that Mounjaro may make the oral contraceptive pill less effective in some patients. Dr Alison Cave, MHRA's chief safety officer, said: 'Evidence shows that almost a third of side effects to medicines could be prevented with the introduction of genetic testing, it is predicted that adverse drug reactions could cost the NHS more than £2.2 billion a year in hospital stays alone. 'Information from the Yellow Card Biobank will help us to better predict those most at risk of adverse reactions – enabling patients across the UK to receive the safest medicine for them, based on their genetic makeup. 'To help us help you, we're asking anyone who has been hospitalised with acute pancreatitis while taking a GLP-1 medicine to report this to us via our Yellow Card scheme. 'Even if you don't meet the criteria for this phase of the Biobank study, information about your reaction to a medication is always extremely valuable in helping to improve patient safety.' Professor Matt Brown, chief scientific officer of Genomics England, said: 'GLP-1 medicines like Ozempic and Wegovy have been making headlines, but like all medicines there can be a risk of serious side effects. 'We believe there is real potential to minimise these with many adverse reactions having a genetic cause. 'This next step in our partnership with the MHRA will generate data and evidence for safer and more effective treatment through more personalised approaches to prescription, supporting a shift towards an increasingly prevention-focused healthcare system.'
Yahoo
8 hours ago
- Yahoo
The three lifestyle factors putting a million UK adults at risk of dying early
About a million people in England are putting themselves at risk of dying early because they are overweight and combine drinking too much and smoking, research has found. The 'triple threat' disproportionately raises their risk of diseases including cancer, heart disease, stroke, Type-2 diabetes, liver disease and mental health conditions, experts warn. One doctor said the combination may cut 20 years from someone's life. Analysis of a Health Survey for England by charity Action on Smoking and Health (Ash) found that 22 per cent of adults in England – at least 10 million people – have two or more of the three risk factors. About 2 per cent – a million adults – fall into all three categories. Public-health experts warned two years ago that high levels of obesity, excessive drinking and health inequalities were costing the economy £15bn a year. Professor Sir Ian Gilmore, chairman of the Alcohol Health Alliance, said each of the three habits carried a risk, but when combined the danger is exaggerated. 'These poor health outcomes are not only avoidable, but they also place a huge and growing strain on the NHS and our economy,' he said. "We urgently need a joined-up approach to public health policymaking that tackles these issues together, rather than in isolation, if we are to see the much-needed governmental shift from sickness to prevention.' The combined effects of smoking, drinking and being overweight are often greater than the sum of individual risks, studies have shown. The new analysis of 2021 data also found that: ● 5.9 million people (13 per cent of adults) have factors of being overweight or obesity and drinking ● 2.5 million (6 per cent of adults) are overweight or obese and smoke ● 0.6 million (1 per cent of adults) drink and smoke without being overweight Prof Gilmore, a former president of the Royal College of Physicians, told The Guardian it was likely that smoking, grade three obesity and heavy drinking would reduce life expectancy by at least 20 years. Katharine Jenner, director of the Obesity Health Alliance, said: 'These are not issues of individual behaviour, but issues of industry behaviour or tactics. 'Behind the statistics on smoking, alcohol and unhealthy food-related disease lie multi-million-pound industries that operate in darkly similar ways – producing, marketing and selling products that damage our wellbeing. 'The government will not be able to meet its ambition of shifting from prevention to treatment until it recognises this.' Caroline Cerny, the deputy chief executive of Ash, said the government's forthcoming 10-year plan was an opportunity to 'get a firm grip on the causes of ill health that are shortening the lives of people and placing a huge strain on the NHS'. She called for targets to cut smoking, drinking and excess weight, introducing minimum-unit pricing of alcohol in England and extending the sugar tax. Health secretary Wes Streeting is next week due to unveil his 10-year plan for the NHS, aimed at tackling inequalities through fundamental reforms, and measures such as sending health workers door-to-door. People will be urged to monitor their own health with technology such as smart watches that monitor blood pressure and glucose levels. The Department of Health and Social Care was approached for comment but a spokesperson told The Guardian ministers were committed to tackling obesity through a ban on the advertising of junk food on television before 9pm and a planned new food strategy. They also an extra £310m had been put to treatment of drug and alcohol addiction, while the Tobacco and Vapes Bill phases out the sale of cigarettes.
Yahoo
10 hours ago
- Yahoo
Carrie Johnson hospitalised with severe dehydration after giving birth
Carrie Johnson has revealed she was hospitalised for two nights with severe dehydration as she issued a warning to other breastfeeding mothers ahead of the heatwave. The wife of former Prime Minister Boris Johnson shared details of her ordeal on Instagram, posting from her hospital bed with her newborn baby in her arms. 'Being hospitalised for two nights for severe dehydration was not on my postpartum bingo card,' she wrote, alongside a photo of her and her baby in a hospital ward. 'Breastfeeding mums make sure you eat and drink enough in this heat. Especially if your babe is clusterfeeding.' Mrs Johnson, who gave birth to her third child earlier this year, said the week had been 'brutal', revealing that she had also suffered mastitis while her baby was struggling with reflux. 'This week has honestly been brutal,' she wrote in a second post. 'Mastitis (me), Reflux (her), Dehydration (me). What a pair we are! 'But thank you for all the kindest messages, especially all the brilliant advice on reflux. Really appreciate it and made me feel way less alone going thru it all. 'And as ever, thanks to our amazing NHS.' Mrs Johnson has previously spoken about her postpartum experiences and has used her social media to advocate for maternal health awareness. The couple welcomed their third child, a son named Frank, in July 2023. The UK is set to experience its second heatwave of the year, with temperatures climbing above 30C in parts of the country and the Met Office issuing health alerts for vulnerable groups including the elderly, young children, and new mothers.
